SEARCH

SEARCH BY CITATION

References

  • 1
    Compston JE, Judd D, Crawley EO, et al. Osteoporosis in patients with inflammatory bowel disease. Gut 1987; 28: 410 15.
  • 2
    Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn’s disease. Gastroenterology 1982; 83: 1252 8.
  • 3
    Vogelsang H, Ferenci P, Woloszczuk W, et al.Bone disease in vitamin D-deficient patients with Crohn’s disease. Dig Dis Sci 1989; 34: 1094 9.
  • 4
    Baylink DJ. Glucocorticosteroid-induced osteoporosis. N Engl J Med 1983; 300: 306 8.
  • 5
    Peck W, Gennari C, Raisz L, et al. Corticosteroids and bone. Calcif Tissue Int 1984; 36: 4 7.
  • 6
    Brattsand R, Thale’n A, Roempke K, Kallström L, Gruvstad E. Influence of 16 alpha, 17 alpha-acetal substitution and steroid nuclear fluorination on the topical to systemic activity ratio of glucocorticosteroids. J Steroid Biochem 1982; 16: 779 86.
  • 7
    Brattsand RL. Steroid development: a case of enhanced selectivity for the bowel wall. In: Jewell DP, Rutgeerts P, eds. Reviewing Steroids in the Treament of IBD. Res Clin Forum 1993; 15(5): 17 33.
  • 8
    Edsbäcker S, Wollmer P, Nilsson A, Nilsson M. Pharmacokinetics and gastrointestinal transit of budesonide controlled-ileal-release (CIR) capsules. Gastroenterology 1993; 104: A695.
  • 9
    Löfberg R, Danielsson A, Salde L. Oral budesonide in active ileal Crohn’s disease—a pilot trial with a topically acting steroid. Aliment Pharmacol Ther 1993; 7: 611 16.
  • 10
    Greenberg GR, Feagan BG, Martin F, et al.Oral budesonide for active Crohn’s disease. N. Engl J Med 1994; 331: 836 41.
  • 11
    Rutgeerts P, Löfberg R, Malchow H, et al. A comparison of budesonide with prednisolone for active Crohn’s disease. N Engl J Med 1994; 331: 842 5.
  • 12
    Campieri C, Ferguson A, Doe W & the International Budesonide Study Group. Oral budesonide compares favorably with prednisolone in active Crohn’s disease. Gastroenterology 1995; 108: A790.
  • 13
    Bouillon R, Vanderschueren D, Van Herck E. et al. Homologous radioimmunoassay of human osteocalcin. Clin Chem 1992; 38: 2055 60.
  • 14
    Yoshioka T, Sato B, Matsumoto K, Ono K. Steroid receptors in osteoblasts. Clin Orthop 1980; 148: 297 303.
  • 15
    Peck WA. The effects of glucocorticosteroids on bone cell metabolism and function. In: Avioli LV, Gennari C, Imbimbo BP, eds. Glucocorticoid Effects and Their Biological Consequences, Volume 171. New York: Plenum Press, 1984; 111–19.
  • 16
    Brissot C, Meunier PJ, Chapuy MC. Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metab Bone Dis 1979; 1: 303 11.
  • 17
    Silvennoinen JA, Kartunen TJ, Niemelä SE, Manelius JJ, Lehtola JK. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 1995; 37: 71 6.
  • 18
    Price PA, Parthemore JG, Deftos LJ. New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone Gla protein in the plasma of normal subjects and patients with bone disease. J Clin Invest 1980; 66: 878 83.